{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:15:23Z","timestamp":1792556123027,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijrobp.2023.11.060","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T09:00:57Z","timestamp":1701766857000},"page":"1011-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Normal Tissue Complication Probability Modeling of Severe Radiation-Induced Lymphopenia Using Blood Dose for Patients With Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-3039","authenticated-orcid":false,"given":"Seohan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Kyung","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-0646","authenticated-orcid":false,"given":"Wonmo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.11.060_bib0001","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2021.11.008","article-title":"Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellualr carcinoma","volume":"112","author":"Sung","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2022.01.007","article-title":"Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy","volume":"168","author":"Cho","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09553009414550241","article-title":"Radiation response of mouse lymphoid and myeloid cell lines. Part I. Sensitivity to killing by ionizing radiation, rate of loss of viability, and cell type of origin","volume":"65","author":"Radford","year":"1994","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41419-018-1095-7","article-title":"Sensitivity of CD3\/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: Key role of ATM in the differential radiation response","volume":"9","author":"Heylmann","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0006","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: A systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0007","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0008","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlenther onkol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0009","doi-asserted-by":"crossref","first-page":"1119173","DOI":"10.3389\/fonc.2023.1119173","article-title":"Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on Circulating blood cells","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0010","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.21873\/anticanres.13620","article-title":"Lymphopenia as a potential predictor of ipsilateral breast tumor recurrence in early breast cancer","volume":"39","author":"Cho","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0011","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0012","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0014","doi-asserted-by":"crossref","first-page":"164001","DOI":"10.1088\/1361-6560\/ac16ea","article-title":"HEDOS - a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations","volume":"66","author":"Shin","year":"2021","journal-title":"Physics in Medicine & Biology"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2006.10.009","article-title":"Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs?","volume":"108","author":"Blum","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0016","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2020.02.015","article-title":"The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy","volume":"146","author":"Xu","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0017","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0018","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab6c41","article-title":"4D blood flow model for dose calculation to circulating blood and lymphocytes","volume":"65","author":"Hammi","year":"2020","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2023.01.054","article-title":"Predicting Severity of Radiation Induced Lymphopenia in Individualized Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulatioins","volume":"116","author":"McCullum","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0146-6453(03)00002-2","article-title":"Basic anatomical and physiological data for use in radiological protection: Reference values. ICRP publication 89","volume":"32","author":"Valentin","year":"2002","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0022","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1118\/1.596781","article-title":"Clinically relevant optimization of 3-D conformal treatments","volume":"19","author":"Mohan","year":"1992","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2019.07.006","article-title":"Normal tissue complication probability (NTCP) models for modern radiation therapy","volume":"46","author":"Palma","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0024","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1118\/1.3685447","article-title":"The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM","volume":"39","author":"Li","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0025","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","article-title":"Dosimetric analysis and normal-tissue complication probability modeling of Child-Pugh score and albumin-bilirubin grade increase after hepatic irradiation","volume":"107","author":"Pursley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0026","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1109\/TPAMI.2009.187","article-title":"Sensitivity analysis of k-fold cross validation in prediction error estimation","volume":"32","author":"Rodriguez","year":"2009","journal-title":"IEEE Transactions on Pattern Analysis and Machine Intelligence"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0027","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/s41598-021-81058-1","article-title":"Comparison of DNA repair and radiosensitivity of different blood cell populations","volume":"11","author":"Heylmann","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0028","first-page":"223","article-title":"Assessment of DNA damage and chromosome aberration in human lymphocyte exposed to low dose radiation detected by FISH (fluorescence in situ hybridization) and SCGE (single cell gel electrophoresis)","volume":"25","author":"Chung","year":"2000","journal-title":"J Radiat Prot"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0029","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.adro.2020.03.021","article-title":"Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma","volume":"5","author":"So","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0031","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1039\/c3lc50432h","article-title":"Micro-scale blood plasma separation: From acoustophoresis to egg-beaters","volume":"13","author":"Kersaudy-Kerhoas","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1172\/JCI102917","article-title":"The fate of P32 labelled diisopropylfluorophosphonate in the human body and its use as a labelling agent in the study of the turnover of blood plasma and red cells","volume":"33","author":"Cohen","year":"1954","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0033","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13014-020-01494-7","article-title":"Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: Impact of treatment modality and the baseline lymphocyte count","volume":"15","author":"Xie","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0034","article-title":"Radiation induced lymphopenia is associated with the effective dose to the circulating immune cells in breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0035","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","article-title":"Lymphocyte depletion during treatment with intensive chemotherapy for cancer","volume":"84","author":"Mackall","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0036","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.v13.i2.280","article-title":"Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma","volume":"13","author":"Nagai","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0038","first-page":"9","article-title":"Acridine orange stained micronucleus assay in human B and T-lymphocytes after low dose gamma irradiation","volume":"29","author":"Choi","year":"2004","journal-title":"J Radiat Prot"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0039","doi-asserted-by":"crossref","first-page":"e27357","DOI":"10.4161\/onci.27357","article-title":"Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7\/IL-15 response among high-grade glioma patients treated with radiation and temozolomide","volume":"3","author":"Ellsworth","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11060-017-2580-z","article-title":"Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide","volume":"135","author":"Campian","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0041","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1078-0432.CCR-16-1432","article-title":"Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T cells","volume":"23","author":"Tang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.060_bib0042","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:18:24Z","timestamp":1729091904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623081865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0360301623081865"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.060","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal Tissue Complication Probability Modeling of Severe Radiation-Induced Lymphopenia Using Blood Dose for Patients With Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}